CBD and Seizures: New Clinical Evidence Challenges Common Beliefs

CBD and Seizures: New Clinical Evidence Challenges Common Beliefs   Introduction CBD and seizures research has skyrocketed in recent years, challenging traditional treatment paradigms for refractory epilepsy. Epilepsy affects approximately 50 million people globally, according to the World Health Organization (WHO). This neurological disorder, previously limited

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis Please like and subscribe if you enjoyed this video :-)    Abstract The treatment landscape for managing weight in non-diabetic patients has changed dramatically with the introduction of

Tool for evaluating real world evidence in treatment of retinal disease

Tool for Evaluating RWE in the Treatment of Retinal Disease   Randomized clinical trials have long been held as the gold standard for evidence based medical practices. However, there is a growing consciousness about the value of incorporating data from real world evidence (RWE) into clinical decision making. Information from real world sources such

CBD and Seizures: New Clinical Evidence Challenges Common Beliefs